Magnera Posts $37 Million Operating Loss for Fiscal 2026

The packaging materials maker's annual results were weighed down by $106 million in goodwill and other impairments.

Updated on Nov. 18, 2026 in Corporate Finance

Stacked rolls of translucent polymer film in a bare concrete warehouse bay under flat overcast daylight.
Magnera Corporation reported a $37 million fiscal 2026 operating loss on $3.3 billion in net sales after $106 million in goodwill and other impairment charges. AI Illustration. Upload story photo >

Magnera Corporation reported a GAAP operating loss of $37 million for fiscal year 2026 on GAAP net sales of $3.3 billion, after recording $106 million of goodwill and other impairment charges. Its fourth-quarter net sales reached $851 million, though the quarter still produced a $90 million GAAP operating loss.

Why it matters

The results show a company absorbing large non-cash write-downs while still generating positive cash flow and paying down debt. Investors are watching whether the company's cost initiatives can translate into stronger earnings in fiscal year 2027.

Fiscal 2026 adjusted EBITDA was $378 million, and the company expects fiscal 2027 adjusted EBITDA of $390 to $410 million. Fourth-quarter operating cash flow of $99 million funded debt repayment of $57 million in the quarter.

The players

Magnera Corporation

Magnera is a publicly traded packaging materials company headquartered in Charlotte, North Carolina, that reports results for its Americas and Europe segments.

The details

Magnera attributed the fourth-quarter sales increase to $43 million of higher selling prices passed through from raw material costs, partly offset by a 4% organic volume decline. The volume drop was tied to softer healthcare demand in the Americas and general market weakness in Europe.

Timeline

  1. September 26, 2026: Magnera's fiscal year 2026 ended.

  2. November 18, 2026: Fourth-quarter and fiscal year 2026 results were announced from Charlotte, N.C.

  3. November 19, 2026: The company held an investor conference call on the results.

Corporate Finance Context

Magnera's margin improvement in the Americas is credited to realized benefits from its Project CORE cost program and merger synergies. Those gains were offset at the group level by the fourth-quarter volume decline and the impairment charge.

For shareholders and bondholders, the impairment and operating loss signal weaker reported earnings even as debt is being reduced. Investors tracking the stock or credit should weigh the company's fiscal 2027 cash flow guidance against its reported losses.

The takeaway

Strong cash generation and debt repayment can coexist with large non-cash write-downs, so investors should look at cash flow alongside reported operating results. Magnera's fiscal 2027 guidance will show whether its cost initiatives begin to lift earnings.

What happens next

Magnera expects to report fiscal year 2027 results against its guidance of $390 to $410 million adjusted EBITDA and $110 to $130 million free cash flow.

Further reading

For related coverage, see Corporate Finance reporting on how companies manage impairments and debt.